Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.60% | -- | |||
| Total Other Revenue | -3.04% | -9.91% | |||
| Total Revenue | -3.04% | -8.84% | |||
| Cost of Revenue | -3.04% | 24.87% | |||
| Gross Profit | 3.04% | -34.25% | |||
| SG&A Expenses | -3.04% | -28.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -3.15% | 177.67% | |||
| Total Operating Expenses | -3.04% | 14.00% | |||
| Operating Income | 3.04% | -18.64% | |||
| Income Before Tax | 3.04% | -8.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.04% | -8.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.04% | -8.34% | |||
| EBIT | 3.04% | -18.64% | |||
| EBITDA | 3.04% | -15.43% | |||
| EPS Basic | 3.03% | 17.41% | |||
| Normalized Basic EPS | 3.08% | 17.30% | |||
| EPS Diluted | 3.00% | 16.50% | |||
| Normalized Diluted EPS | 3.08% | 17.30% | |||
| Average Basic Shares Outstanding | 0.00% | 31.12% | |||
| Average Diluted Shares Outstanding | 0.00% | 31.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||